The Patent Finder

Spray Ejector Mechanisms and Devices Providing Charge Isolation and Controllable Droplet Charge, and Low Dosage Volume Ophthalmic Administration

Hyperion Defi, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/US2013/036002, filed Apr 10, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,110,000Spray Ejector Mechanisms and Devices Providing Charge Isolation and Controllable Droplet Charge, and Low Dosage Volume Ophthalmic Administration
In force
 · High confidence
Hyperion Defi, Inc.In force
High confidence
US 12,029,682Spray Ejector Mechanisms and Devices Providing Charge Isolation and Controllable Droplet Charge, and Low Dosage Volume Ophthalmic Administration
In force
 · High confidence
Hyperion Defi, Inc.In force
High confidence
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited